Anavex Life Sciences
AVXL
#8378
Rank
HK$2.48 B
Marketcap
HK$26.76
Share price
-2.85%
Change (1 day)
-68.38%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -HK$0.32 Billion

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. , an increase over its 2024 earnings that were of -HK$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 -HK$0.32 Billion-22.43%
2024 -HK$0.41 Billion14.77%
2023 -HK$0.36 Billion-17.49%
2022 -HK$0.43 Billion22.96%
2021 -HK$0.35 Billion35.36%
2020 -HK$0.26 Billion12.65%
2019 -HK$0.23 Billion29.09%
2018 -HK$0.18 Billion36.33%
2017 -HK$0.13 Billion17.11%
2016 -HK$0.12 Billion20.91%
2015 -HK$91.43 Million-6.29%
2014 -HK$97.57 Million337.28%
2013 -HK$22.32 Million
2008 -HK$41.27 Million106.01%
2007 -HK$20.03 Million8848.98%
2006 -HK$0.23 Million-79.99%
2005 -HK$1.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
HK$1.49 B-576.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
-HK$64.5 Million-79.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$48.98 Million-84.39%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-HK$3.57 Billion 1,035.69%๐Ÿ‡บ๐Ÿ‡ธ USA